Literature DB >> 3121225

Serum neuraminidase activity and hematological alterations in acute human Chagas' disease.

E H de Titto1, F G Araujo.   

Abstract

Neuraminidase activity was detected in serum 12 days after an accidental laboratory infection with Trypanosoma cruzi, peaked at the time when clinical symptoms appeared, and dropped to undetectable values by the day antibodies specific for T. cruzi were first demonstrated. A seric factor blocking neuraminidase activity was demonstrated when antibodies were first detected and persisted with high titers for at least 12 weeks thereafter. Erythrocyte and white blood cell counts as well as hemoglobin and hematocrit were below the lower limit of normality when seric neuraminidase activity was at its peak.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121225     DOI: 10.1016/0090-1229(88)90016-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  23 in total

1.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases.

Authors:  S Kahn; T G Colbert; J C Wallace; N A Hoagland; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

5.  Differential expression of Trypanosoma cruzi neuraminidase in intra- and extracellular trypomastigotes.

Authors:  I A Rosenberg; R P Prioli; J S Mejia; M E Pereira
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

6.  A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells.

Authors:  M V Chuenkova; M A Pereira
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

7.  Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.

Authors:  Pablo Ruiz Díaz; Juan Mucci; María Ana Meira; Yanina Bogliotti; Daniel Musikant; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

8.  Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.

Authors:  N M Alcântara-Neves; L C Pontes-de-Carvalho
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

9.  Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity.

Authors:  M S Leguizamón; O E Campetella; S M González Cappa; A C Frasch
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Alterations in the surface charge of heart muscle cells during interaction with Trypanosoma cruzi.

Authors:  M de N Soeiro; F Costa e Silva Filho; M de N Leal de Meirelles
Journal:  Cell Biophys       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.